These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 8397126)

  • 1. Reduced motor nerve conduction velocity and Na(+)-K(+)-ATPase activity in rats maintained on L-fucose diet. Reversal by myo-inositol supplementation.
    Yorek MA; Wiese TJ; Davidson EP; Dunlap JA; Stefani MR; Conner CE; Lattimer SA; Kamijo M; Greene DA; Sima AA
    Diabetes; 1993 Oct; 42(10):1401-6. PubMed ID: 8397126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced Na+/K+ adenosine triphosphatase activity and motor nerve conduction velocity in L-fucose-fed rats is reversible after dietary normalization.
    Yorek MA; Wiese TJ; Davidson EP; Dunlap JA; Conner CE
    Metabolism; 1996 Feb; 45(2):229-34. PubMed ID: 8596495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats.
    Mizuno K; Kato N; Matsubara A; Nakano K; Kurono M
    Metabolism; 1992 Oct; 41(10):1081-6. PubMed ID: 1328819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supplemental myo-inositol prevents L-fucose-induced diabetic neuropathy.
    Sima AA; Dunlap JA; Davidson EP; Wiese TJ; Lightle RL; Greene DA; Yorek MA
    Diabetes; 1997 Feb; 46(2):301-6. PubMed ID: 9000708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normalization of Na(+)-K(+)-ATPase activity in isolated membrane fraction from sciatic nerves of streptozocin-induced diabetic rats by dietary myo-inositol supplementation in vivo or protein kinase C agonists in vitro.
    Kim J; Kyriazi H; Greene DA
    Diabetes; 1991 May; 40(5):558-67. PubMed ID: 1850704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of treating streptozotocin-induced diabetic rats with sorbinil, myo-inositol or aminoguanidine on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve.
    Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Yorek MA
    Int J Exp Diabetes Res; 2002; 3(1):21-36. PubMed ID: 11900277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired rat sciatic nerve sodium-potassium adenosine triphosphatase in acute streptozocin diabetes and its correction by dietary myo-inositol supplementation.
    Greene DA; Lattimer SA
    J Clin Invest; 1983 Sep; 72(3):1058-63. PubMed ID: 6309904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Action of sorbinil in diabetic peripheral nerve. Relationship of polyol (sorbitol) pathway inhibition to a myo-inositol-mediated defect in sodium-potassium ATPase activity.
    Greene DA; Lattimer SA
    Diabetes; 1984 Aug; 33(8):712-6. PubMed ID: 6086432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil.
    Tomlinson DR; Moriarty RJ; Mayer JH
    Diabetes; 1984 May; 33(5):470-6. PubMed ID: 6202576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetyl-L-carnitine deficiency as a cause of altered nerve myo-inositol content, Na,K-ATPase activity, and motor conduction velocity in the streptozotocin-diabetic rat.
    Stevens MJ; Lattimer SA; Feldman EL; Helton ED; Millington DS; Sima AA; Greene DA
    Metabolism; 1996 Jul; 45(7):865-72. PubMed ID: 8692023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine triphosphatase activity in sciatic nerve tissue of streptozocin-induced diabetic rats with and without high dietary sucrose: effect of aldose reductase inhibitors.
    Sredy J; Flam BR; Sawicki DR
    Proc Soc Exp Biol Med; 1991 Jun; 197(2):135-43. PubMed ID: 1851565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amelioration of nerve Na(+)-K(+)-ATPase activity independently of myo-inositol level by PGE1 analogue OP-1206.alpha-CD in streptozocin-induced diabetic rats.
    Sonobe M; Yasuda H; Hisanaga T; Maeda K; Yamashita M; Kawabata T; Kikkawa R; Taniguchi Y; Shigeta Y
    Diabetes; 1991 Jun; 40(6):726-30. PubMed ID: 1645681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of nerve conduction deficit in diabetic rats by polyunsaturated fatty acids.
    Head RJ; McLennan PL; Raederstorff D; Muggli R; Burnard SL; McMurchie EJ
    Am J Clin Nutr; 2000 Jan; 71(1 Suppl):386S-92S. PubMed ID: 10618002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased myo-inositol content and Na+-K+-ATPase activity in superior cervical ganglion of STZ-diabetic rat and prevention by aldose reductase inhibition.
    Greene DA; Mackway AM
    Diabetes; 1986 Oct; 35(10):1106-8. PubMed ID: 3019804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of myo-inositol on renal Na-K-ATPase in experimental diabetes.
    Cohen RA; MacGregor LC; Spokes KC; Silva P; Epstein FH
    Metabolism; 1990 Oct; 39(10):1026-32. PubMed ID: 2170818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat.
    Stevens MJ; Lattimer SA; Kamijo M; Van Huysen C; Sima AA; Greene DA
    Diabetologia; 1993 Jul; 36(7):608-14. PubMed ID: 8359577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A sodium-pump defect in diabetic peripheral nerve corrected by sorbinil administration: relationship to myo-inositol metabolism and nerve conduction slowing.
    Greene DA
    Metabolism; 1986 Apr; 35(4 Suppl 1):60-5. PubMed ID: 2421135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chronic alpha-adrenergic receptor blockade on peripheral nerve conduction, hypoxic resistance, polyols, Na(+)-K(+)-ATPase activity, and vascular supply in STZ-D rats.
    Cameron NE; Cotter MA; Ferguson K; Robertson S; Radcliffe MA
    Diabetes; 1991 Dec; 40(12):1652-8. PubMed ID: 1661693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats.
    Mayer JH; Tomlinson DR
    Diabetologia; 1983 Nov; 25(5):433-8. PubMed ID: 6197336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the aldose reductase inhibitor tolrestat on nerve conduction velocity, Na/K ATPase activity, and polyols in red blood cells, sciatic nerve, kidney cortex, and kidney medulla of diabetic rats.
    Raccah D; Coste T; Cameron NE; Dufayet D; Vague P; Hohman TC
    J Diabetes Complications; 1998; 12(3):154-62. PubMed ID: 9618071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.